Saturday 17 October 2026
Export BRKR’s income statement to Excel — free account
Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.
54.80
1.74
−3.08%
Follow BRKR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
22.72 | 69.04 | 25.89 | 39.82 | 52.55 | 45.85 | 34.54 | 24.76 | 77.13 | 0.00 |
Piotroski F-Score |
7 | 7 | 7 | 6 | 5 | 8 | 5 | 6 | 3 | 4 |
Altman Z-Score |
4.25 | 5.15 | 4.70 | 4.81 | 4.41 | 5.15 | 4.69 | 4.33 | 2.77 | 2.43 |
P/S ratio |
2.16 | 3.09 | 2.45 | 3.82 | 4.18 | 5.25 | 4.06 | 3.57 | 2.59 | 2.08 |
P/FCF ratio |
29.12 | 37.13 | 21.56 | 44.90 | 31.94 | 57.72 | 55.81 | 39.50 | 54.32 | 105.01 |
Altman Z″-Score (non-manufacturers) |
5.65 | 5.78 | 5.47 | 5.47 | 4.98 | 5.44 | 5.20 | 4.47 | 2.99 | 2.98 |
Beneish M-Score |
(2.41) | (2.37) | (2.26) | (2.60) | (2.79) | (2.38) | (2.20) | (2.23) | (2.28) | (2.56) |
P/Operating CF |
38.36 | 52.63 | 35.15 | 58.08 | 40.90 | 91.66 | 59.85 | 51.51 | 45.97 | 31.12 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 34 |
P/B ratio |
5.03 | 7.44 | 5.14 | 8.63 | 8.52 | 11.71 | 9.12 | 7.59 | 4.86 | 2.89 |
Price to Tangible BV |
7.07 | 11.34 | 11.32 | 20.24 | 19.55 | 23.82 | 25.84 | 21.98 | 0.00 | 272.95 |
EV/Sales |
2.11 | 3.08 | 2.46 | 3.88 | 4.23 | 5.32 | 4.28 | 3.84 | 3.16 | 2.54 |
EV/EBITDA |
14.38 | 19.17 | 14.26 | 21.35 | 25.60 | 25.62 | 20.78 | 20.62 | 24.37 | 30.23 |
EV/Operating CF |
25.95 | 35.20 | 19.48 | 37.67 | 25.33 | 45.57 | 39.50 | 32.50 | 42.36 | 65.04 |
EV/FCF |
28.38 | 36.97 | 21.64 | 45.62 | 32.37 | 58.47 | 58.93 | 42.45 | 66.20 | 128.07 |
Quick Ratio |
1.42 | 1.45 | 1.13 | 1.62 | 1.35 | 1.69 | 1.22 | 0.82 | 0.58 | 0.66 |
Current Ratio |
2.43 | 2.59 | 2.18 | 2.78 | 2.43 | 2.63 | 2.31 | 1.80 | 1.60 | 1.73 |
Net Debt/EBITDA |
(0.38) | (0.08) | 0.06 | 0.34 | 0.34 | 0.33 | 1.10 | 1.44 | 4.37 | 5.44 |
Debt/Assets |
22.77% | 21.33% | 16.02% | 29.35% | 27.70% | 36.55% | 33.76% | 30.15% | 36.07% | 29.95% |
Debt/Equity |
0.59 | 0.57 | 0.38 | 0.89 | 0.87 | 1.23 | 1.08 | 0.92 | 1.17 | 0.76 |
Asset Turnover |
0.91 | 0.94 | 0.93 | 0.85 | 0.68 | 0.72 | 0.70 | 0.75 | 0.67 | 0.57 |
Operating CF/Net income |
0.85 | 1.96 | 1.33 | 1.08 | 2.11 | 1.02 | 0.93 | 0.82 | 2.22 | (5.96) |
Capex/Depreciation |
(0.66) | (0.50) | (0.75) | (0.82) | (1.21) | (0.98) | (1.30) | (0.93) | (0.63) | (0.41) |
| 21.54% | 11.02% | 21.93% | 21.64% | 16.69% | 26.92% | 26.84% | 33.90% | 7.09% | (1.05%) | |
| 8.68% | 4.18% | 8.82% | 8.05% | 5.42% | 8.27% | 8.17% | 10.87% | 2.25% | (0.37%) | |
ROIC |
18.80% | 19.32% | 17.75% | 17.99% | 14.28% | 20.66% | 15.91% | 12.48% | 4.27% | 1.05% |
Return on Tangible Assets |
15.51% | 7.14% | 18.42% | 13.54% | 10.32% | 14.29% | 17.59% | 27.35% | 7.85% | (1.34%) |
Average Days of Receivables |
55.25 | 66.00 | 68.78 | 63.79 | 61.58 | 62.93 | 68.18 | 60.58 | 61.31 | 57.88 |
Research and Development Expense of Revenue |
9.18% | 9.15% | 9.15% | 9.06% | 9.96% | 9.13% | 9.32% | 9.94% | 11.18% | 11.50% |
Selling, General and Administrative Expense of Revenue |
24.19% | 23.51% | 23.46% | 24.13% | 23.58% | 23.21% | 24.00% | 24.60% | 26.55% | 27.54% |
Intangible Assets out of Total Assets |
0.11 | 0.13 | 0.23 | 0.19 | 0.18 | 0.15 | 0.20 | 0.21 | 0.42 | 0.39 |
Share Based Compensation of Revenue |
0.58% | 0.62% | 0.60% | 0.46% | 0.81% | 0.71% | 1.09% | 1.04% | 0.75% | 0.59% |
Graham Net Nets |
0.05 | 0.03 | 0.02 | (0.01) | (0.02) | (0.01) | (0.04) | (0.07) | (0.22) | (0.22) |
Graham Number |
9.58 | 7.22 | 12.24 | 13.05 | 12.13 | 17.17 | 18.46 | 25.02 | 14.36 | 0.00 |
Earnings Yield |
4.40% | 1.45% | 3.86% | 2.51% | 1.90% | 2.18% | 2.90% | 4.04% | 1.30% | (0.32%) |
Free Cash Flow Yield |
3.43% | 2.69% | 4.64% | 2.23% | 3.13% | 1.73% | 1.79% | 2.53% | 1.84% | 0.95% |
Revenue per Share |
9.98 | 11.17 | 12.14 | 13.35 | 12.96 | 15.97 | 17.03 | 20.25 | 22.59 | 22.64 |
Operating CF per Share |
0.81 | 0.98 | 1.53 | 1.38 | 2.17 | 1.87 | 1.85 | 2.39 | 1.69 | 0.88 |
Capex per Share |
(0.22) | (0.20) | (0.31) | (0.40) | (0.63) | (0.58) | (0.78) | (0.73) | (0.77) | (0.60) |
Free Cash Flow per Share |
0.59 | 0.77 | 1.22 | 0.98 | 1.53 | 1.29 | 1.07 | 1.66 | 0.91 | 0.29 |
Cash per Share |
3.10 | 2.78 | 2.06 | 4.41 | 4.77 | 7.72 | 4.34 | 3.34 | 1.23 | 1.97 |
Shareholders Equity per Share |
4.29 | 4.64 | 5.79 | 5.91 | 6.35 | 7.16 | 7.58 | 9.53 | 12.06 | 16.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.29 | 4.64 | 5.79 | 5.91 | 6.35 | 7.16 | 7.58 | 9.53 | 12.06 | 16.29 |
Free Cash Flow |
94.80 | 122.20 | 190.90 | 151.40 | 235.20 | 195.30 | 159.10 | 243.20 | 136.00 | 43.30 |
Working Capital |
751.20 | 834.30 | 705.00 | 1,150.70 | 1,133.10 | 1,533.30 | 1,198.90 | 962.10 | 771.90 | 933.30 |
Capital Expenditures |
(36.00) | (32.20) | (48.80) | (62.00) | (97.00) | (87.10) | (115.30) | (106.90) | (115.30) | (90.80) |
Net Current Asset Value |
160.60 | 143.80 | 80.80 | (58.10) | (149.70) | (93.60) | (372.90) | (691.10) | (1,956.40) | (1,555.40) |
EV/EBIT |
18.67 | 24.76 | 17.79 | 26.72 | 33.90 | 31.14 | 25.05 | 26.04 | 42.06 | 127.88 |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 |
Price to Operating Income |
19.16 | 24.86 | 17.72 | 26.29 | 33.44 | 30.74 | 23.72 | 24.23 | 34.51 | 104.86 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.24 | 0.24 | 0.25 | 0.20 | 0.22 | 0.18 | 0.19 | 0.27 | 0.30 |
Cash ROIC |
5.91% | 7.69% | 12.17% | 6.27% | 9.22% | 5.44% | 5.32% | 7.69% | 3.34% | 0.93% |
Accounts Receivable Turnover |
6.73 | 6.27 | 5.60 | 5.76 | 5.70 | 6.43 | 5.69 | 6.15 | 6.37 | 6.19 |
Accounts Payable Turnover |
10.95 | 10.74 | 10.20 | 9.67 | 8.28 | 8.57 | 7.52 | 7.62 | 7.86 | 8.26 |
Inventory Turnover |
2.01 | 2.05 | 2.00 | 1.98 | 1.65 | 1.72 | 1.62 | 1.64 | 1.69 | 1.72 |
Average Days of Payables |
36.29 | 34.89 | 38.31 | 40.12 | 46.89 | 44.53 | 53.16 | 50.98 | 49.77 | 42.39 |
Days of Inventory on Hand |
185.62 | 186.82 | 186.83 | 195.56 | 241.19 | 214.51 | 238.40 | 243.54 | 227.01 | 214.94 |
Average Receivables |
239.30 | 281.60 | 338.25 | 359.70 | 348.75 | 376.10 | 444.80 | 482.35 | 528.75 | 555.20 |
Average Payables |
79.10 | 88.45 | 97.65 | 111.45 | 126.50 | 141.00 | 162.90 | 190.55 | 218.40 | 225.00 |
Average Inventory |
431.20 | 463.30 | 497.90 | 543.40 | 634.75 | 701.20 | 755.10 | 884.20 | 1,018.05 | 1,081.20 |
Average Assets |
1,769.20 | 1,878.45 | 2,038.55 | 2,450.05 | 2,910.25 | 3,349.50 | 3,630.90 | 3,930.85 | 5,028.30 | 6,024.05 |
Average Common Equity |
713.00 | 713.30 | 819.30 | 911.10 | 945.70 | 1,029.45 | 1,105.15 | 1,260.15 | 1,595.85 | 2,135.30 |
Columns are period end dates